Dr Pelin Batur, a board-certified internist at the Cleveland Clinic in Cleveland, Ohio.
Dr Batur discusses contraception at perimenopause and the hormone and nonhormone options to prevent an unintended pregnancy
The Menopause Society (formerly the North American Menopause Society (NAMS)) presents its comprehensive video series for clinicians about important midlife health topics. All of the interviews in the series are hosted by NAMS Board of Trustees Member and Past-President Dr Marla Shapiro, a Canadian physician, who led this exciting initiative. Dr Shapiro is also the medical consultant for CTV News and on-air medical contributor to Canada AM.
Note: The Australasian Menopause Society does not necessarily endorse the medical and scientific information provided in these videos. As the medical and scientific information provided here might not be relevant to a particular person's circumstances and you should always discuss your health with your own healthcare provider.
Dr Pelin Batur, a board-certified internist at the Cleveland Clinic in Cleveland, Ohio.
Dr Batur discusses contraception at perimenopause and the hormone and nonhormone options to prevent an unintended pregnancy
Dr Wen Shen, NAMS Board Member and assistant professor in the Department of Obstetrics and Gynecology at Johns Hopkins University School of Medicine in Baltimore, Maryland.
Dr Wen Shen discusses the relationship among vasomotor symptoms, cardiovascular health, and genitourinary syndrome of menopause
Dr Samar El Khoudary, NAMS Board Member and associate professor in the Department of Epidemiology and Epidemiology Data Center at the University of Pittsburgh in Pittsburgh, Pennsylvania.
Dr El Khoudary discusses the specific characteristics of menopause that put women at higher risk
Dr Andrew Kaunitz, past NAMS Board Member and professor and associate chair in the Department of Obstetrics and Gynecology at the University of Florida College of Medicine--Jacksonville
Dr Kaunitz reviews why clinicians need to discuss the effects of oral contraceptives in skeletal health with their patients
Dr Chrisandra Shufelt, NAMS President-Elect; associate director, Barbra Streisand Women’s Health Center and Preventive and Rehabilitative Cardiac Center; director, Women’s Hormone and Menopause Program; and associate professor of medicine at Cedars-Sinai Medical Center in Los Angeles, California.
Dr Shufelt discusses what clinicians should consider when determining which women may benefit from statin therapy and the specific risk enhancers involved
Dr Holly Thomas, assistant professor of medicine, General Internal Medicine Department, section of Women’s Health, at the University of Pittsburgh in Pennsylvania.
Dr Thomas reviews how to open the door to a discussion about sexuality and menopause with your patients
Dr Gloria Richard-Davis, executive director, Division of Diversity, Equity, and Inclusion, and professor in the Department of Obstetrics and Gynecology at the University of Arkansas for Medical Sciences
Dr Richard-Davis discusses considerations when prescribing hormone therapies
Dr Vivien Brown, assistant professor at the University of Toronto in Canada.
Dr Brown discusses considerations for the HPV vaccine and your patients
Dr JoAnn Pinkerton
Professor of obstetrics and gynecology and division director of Midlife Health at the University of Virginia Health System in Charlottesville, Virginia, and NAMS Past-President and Executive Director Emeritus.
Dr JoAnn Pinkerton discusses the lack of efficacy and safety data of bioidentical hormone therapy and the safe FDA-approved alternatives
Dr JoAnn Manson
Vhief of the Division of Preventive Medicine at Brigham and Women’s Hospital;
Professor of medicine and the Michael and Lee Bell Professor of Women’s Health at Harvard Medical School, Boston, Massachusetts;
and NAMS Past-President.
Dr JoAnn Manson discusses the role of supplements in preventive health